BRPI0414700A - 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer - Google Patents

6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer

Info

Publication number
BRPI0414700A
BRPI0414700A BRPI0414700-6A BRPI0414700A BRPI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A
Authority
BR
Brazil
Prior art keywords
mammal
compounds
treating
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
BRPI0414700-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Nan Zhang
Semiranis Ayral-Kaloustian
Thai Hiep Nguyen
Yanzhong Wu
Wei Tong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0414700A publication Critical patent/BRPI0414700A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0414700-6A 2003-09-24 2004-09-17 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer BRPI0414700A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50554403P 2003-09-24 2003-09-24
PCT/US2004/030515 WO2005030775A1 (en) 2003-09-24 2004-09-17 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents

Publications (1)

Publication Number Publication Date
BRPI0414700A true BRPI0414700A (pt) 2006-11-14

Family

ID=34393032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414700-6A BRPI0414700A (pt) 2003-09-24 2004-09-17 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer

Country Status (30)

Country Link
US (1) US7507739B2 (enExample)
EP (1) EP1680425B1 (enExample)
JP (1) JP2007506744A (enExample)
KR (1) KR20060098368A (enExample)
CN (1) CN100519559C (enExample)
AR (1) AR045810A1 (enExample)
AU (1) AU2004276240A1 (enExample)
BR (1) BRPI0414700A (enExample)
CA (1) CA2539252A1 (enExample)
CO (1) CO5690598A2 (enExample)
CR (1) CR8288A (enExample)
CY (1) CY1106392T1 (enExample)
DE (1) DE602004004295T8 (enExample)
DK (1) DK1680425T3 (enExample)
EC (1) ECSP066458A (enExample)
ES (1) ES2279452T3 (enExample)
GT (1) GT200400190A (enExample)
IL (1) IL174281A0 (enExample)
MX (1) MXPA06003206A (enExample)
NO (1) NO20061318L (enExample)
PA (1) PA8613301A1 (enExample)
PE (1) PE20050433A1 (enExample)
PL (1) PL1680425T3 (enExample)
PT (1) PT1680425E (enExample)
RU (1) RU2006107579A (enExample)
SA (1) SA04250302A (enExample)
SI (1) SI1680425T1 (enExample)
TW (1) TW200512211A (enExample)
WO (1) WO2005030775A1 (enExample)
ZA (1) ZA200602387B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255309B1 (en) * 1999-03-19 2001-07-03 American Cyanomid Co. Fungicidal trifluoromethylalkylamino-triazolopyrimidines
HK1052646A1 (zh) * 2000-06-30 2003-09-26 Wyeth 替代三氮苯(triazolopyrimidines)作为抗癌剂
US7419982B2 (en) * 2003-09-24 2008-09-02 Wyeth Holdings Corporation Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts
CA2539252A1 (en) 2003-09-24 2005-04-07 Wyeth Holdings Corporation 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
MY179926A (en) * 2003-12-08 2020-11-19 Wyeth Corp Process for the preparation of tubulin inhibitors
CN101193884A (zh) 2005-06-13 2008-06-04 惠氏公司 微管蛋白抑制剂和其制备方法
CA2610416A1 (en) * 2005-06-13 2006-12-28 Wyeth Tubulin inhibitor and process for its preparation
CN101208289A (zh) * 2005-06-27 2008-06-25 巴斯福股份公司 生产取代的苯基丙二酸酯中间体化合物的方法及其在生产5,7-二羟基-6-(2,4,6-三氟苯基)[1,2,4]三唑并[1,5-a]嘧啶中的用途
EP1963330A1 (en) * 2005-12-16 2008-09-03 Wyeth a Corporation of the State of Delaware Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents
JP2009519952A (ja) * 2005-12-16 2009-05-21 ワイス トリアゾロピリミジン化合物の凍結乾燥組成物
US20100056371A1 (en) * 2007-01-08 2010-03-04 Basf Se Use of Azolopyrimidines for Controlling Phytopathogenic Harmful Fungi
WO2014047257A2 (en) 2012-09-19 2014-03-27 The Trustees Of The University Of Pennsylvania Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
US11623927B2 (en) 2018-03-02 2023-04-11 The Trustees Of The University Of Pennsylvania Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules
EP4136089A4 (en) * 2020-04-14 2024-05-29 The Trustees of The University of Pennsylvania SUBSTITUTED {1,2,4,} TRIAZOLO{1,5-A} PYRIMIDINE COMPOUNDS AND THEIR USE IN THE STABILIZATION OF MICROTUBULES
CN114369098B (zh) * 2022-01-06 2023-03-10 苏州大学 一种三唑并嘧啶醇类化合物及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224044B (enExample) 1991-12-30 1994-05-21 Shell Internat Res Schappej B V
US5593996A (en) * 1991-12-30 1997-01-14 American Cyanamid Company Triazolopyrimidine derivatives
JP2794510B2 (ja) 1992-03-27 1998-09-10 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
IL108731A (en) 1993-03-04 1997-03-18 Shell Int Research 6, N-DISUBSTITUTED-£1, 2, 4| TRIAZOLO-£1, 5-a| PYRIMIDINE- 7-AMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES
IL108747A (en) 1993-03-04 1999-03-12 Shell Int Research Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation
RU2147584C1 (ru) 1995-10-27 2000-04-20 Американ Цианамид Компани Способ получения дигалоидазолопиримидинов и способ получения дигидроксиазолопиримидинов
US5817663A (en) 1996-10-07 1998-10-06 American Cyanamid Company Pentafluorophenylazolopyrimidines
ATE231485T1 (de) 1997-03-18 2003-02-15 Basf Ag Verfahren zur herstellung von arylmalonaten
US5750766A (en) 1997-03-18 1998-05-12 American Cyanamid Company Process for the preparation of arylmalonates
TWI252231B (en) 1997-04-14 2006-04-01 American Cyanamid Co Fungicidal trifluorophenyl-triazolopyrimidines
TW460476B (en) 1997-04-14 2001-10-21 American Cyanamid Co Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6117876A (en) 1997-04-14 2000-09-12 American Cyanamid Company Fungicidal trifluorophenyl-triazolopyrimidines
US5948783A (en) 1997-04-14 1999-09-07 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6255309B1 (en) 1999-03-19 2001-07-03 American Cyanomid Co. Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US5994360A (en) 1997-07-14 1999-11-30 American Cyanamid Company Fungicidal 5-alkyl-triazolopyrimidines
CN1114606C (zh) 1998-02-11 2003-07-16 美国氰胺公司 具有杀真菌活性的7－烷基－三唑并嘧啶化合物
US6020338A (en) 1998-02-11 2000-02-01 American Cyanamid Company Fungicidal 7-alkyl-triazolopyrimidines
JPH11322517A (ja) 1998-03-17 1999-11-24 American Cyanamid Co トリアゾロピリミジン類の効力の増進
US6124301A (en) 1998-03-17 2000-09-26 American Cyanamid Company Enhancement of the efficacy of triazolopyrimidines
EA003281B1 (ru) 1998-03-23 2003-04-24 Америкэн Цианамид Компани 6-(2-гало-4-алкоксифенил)триазолпиримидины с фунгицидным действием
US6284762B1 (en) 1998-03-23 2001-09-04 American Cyanamid Company Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines
US5981534A (en) 1998-09-25 1999-11-09 American Cyanamid Company Fungicidal 6-(2,6-difluoro-4-alkoxyphenyl)-triazolopyrimidines
US6117865A (en) 1998-09-10 2000-09-12 American Cyanamid Company Fungicidal trifluorophenyl-triazolopyrimidines
US6268371B1 (en) 1998-09-10 2001-07-31 American Cyanamid Co. Fungicidal mixtures
EP0988790B1 (en) 1998-09-25 2003-05-21 Basf Aktiengesellschaft Fungicidal mixtures
JP2002525291A (ja) 1998-09-25 2002-08-13 アメリカン サイアナミツド コンパニー 非水性懸濁液濃縮物
US5985883A (en) 1998-09-25 1999-11-16 American Cyanamid Company Fungicidal trichlorophenyl-triazolopyrimidines
US6242451B1 (en) 1998-09-25 2001-06-05 Klaus-Juergen Pees Fungicidal trihalophenyl-triazolopyrimidines
US6277856B1 (en) 1998-09-25 2001-08-21 American Cynamid Co. Fungicidal mixtures
JP2000103790A (ja) 1998-09-25 2000-04-11 American Cyanamid Co 殺菌・殺カビ性のトリハロフェニル―トリアゾロピリミジン類
US5986135A (en) 1998-09-25 1999-11-16 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6521628B1 (en) 1999-01-29 2003-02-18 Basf Aktiengesellschaft Fungicidal mixtures
US6699874B2 (en) 1999-09-24 2004-03-02 Basf Aktiengesellschaft Fungicidal mixtures
WO2001035738A2 (en) 1999-11-18 2001-05-25 Basf Corporation Non-aqueous concentrated spreading oil composition
US6559151B2 (en) 2000-05-08 2003-05-06 Basf Aktiengesellschaft 6-(2-trifluoromethyl-phenyl)-triazolopyrimidines
HK1052646A1 (zh) * 2000-06-30 2003-09-26 Wyeth 替代三氮苯(triazolopyrimidines)作为抗癌剂
PT1313370E (pt) 2000-08-25 2004-10-29 Basf Ag Formulacao fungicida
US6459602B1 (en) * 2000-10-26 2002-10-01 O2 Micro International Limited DC-to-DC converter with improved transient response
US6855718B2 (en) 2000-11-13 2005-02-15 Basf Aktiengesellschaft 7-(r)-aminotriazolopyrimidines, the production thereof and use of the same for combatting phytopathogenic fungi
DE60013188T2 (de) 2000-12-06 2004-12-30 Basf Ag Fungiizide 6-(trifluormethyl-phenyl)-triazolpyrimidine
DE10063115A1 (de) 2000-12-18 2002-06-27 Bayer Ag Triazolopyrimidine
WO2002067679A1 (en) 2001-02-19 2002-09-06 Basf Aktiengesellschaft Fungicidal mixtures
BR0208756A (pt) 2001-04-11 2004-05-11 Basf Ag Compostos, processo para a preparação dos mesmos, composição adequada para o controle de fungos fitopatogênicos, e, método para controlar fungos fitopatogênicos
DE10124208A1 (de) 2001-05-18 2002-11-21 Bayer Ag Verwendung von Triazolopyrimidin-Derivaten als Mikrobizide
EP1412356A1 (en) 2001-07-18 2004-04-28 Basf Aktiengesellschaft Substituted 6-(2-methoxyphenyl)triazolopyrimidines as fungicides
CA2539252A1 (en) 2003-09-24 2005-04-07 Wyeth Holdings Corporation 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents

Also Published As

Publication number Publication date
DE602004004295D1 (de) 2007-02-22
PL1680425T3 (pl) 2007-05-31
SA04250302A (ar) 2005-12-03
CY1106392T1 (el) 2011-10-12
GT200400190A (es) 2005-05-02
CA2539252A1 (en) 2005-04-07
DK1680425T3 (da) 2007-03-19
DE602004004295T2 (de) 2007-06-06
WO2005030775A1 (en) 2005-04-07
JP2007506744A (ja) 2007-03-22
ECSP066458A (es) 2006-09-18
HK1090374A1 (en) 2006-12-22
US7507739B2 (en) 2009-03-24
CN100519559C (zh) 2009-07-29
ES2279452T3 (es) 2007-08-16
EP1680425B1 (en) 2007-01-10
RU2006107579A (ru) 2007-10-27
KR20060098368A (ko) 2006-09-18
AU2004276240A1 (en) 2005-04-07
ZA200602387B (en) 2008-11-26
DE602004004295T8 (de) 2007-09-20
PT1680425E (pt) 2007-02-28
CN1867569A (zh) 2006-11-22
EP1680425A1 (en) 2006-07-19
SI1680425T1 (sl) 2007-04-30
AR045810A1 (es) 2005-11-16
NO20061318L (no) 2006-04-21
PA8613301A1 (es) 2005-11-25
IL174281A0 (en) 2006-08-01
CR8288A (es) 2006-10-04
CO5690598A2 (es) 2006-10-31
PE20050433A1 (es) 2005-07-21
US20050090508A1 (en) 2005-04-28
MXPA06003206A (es) 2006-06-23
TW200512211A (en) 2005-04-01

Similar Documents

Publication Publication Date Title
BRPI0414700A (pt) 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer
BRPI0408005A (pt) composto, composição farmacêutica, métodos para inibir angiogênese, atividade de pde4 em uma célula e proliferação de célula de cáncer, para inibir ou reduzir polimerização de tubulina ou estabilidade de tubulina em uma célula, para tratar ou melhorar um distúrbio inflamatório, um cáncer e um distúrbio do sistema nervoso central e para visar, bloquear ou destruir a função de vasculatura de tumor e o endotélio de vasos de tumor
MX383644B (es) Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
BRPI0416656A (pt) compostos de pirrolopirimidina úteis no tratamento do cáncer
BRPI0513836A (pt) composto, métodos de tratar, controlar ou prevenir cáncer, uma doença associada com angiogênese indesejada, e uma doença ou distúrbio mediado por pde 4, e de reduzir ou inibir o nìvel ou a atividade de pde 4 em um paciente, e, composição farmacêutica
BRPI0518315B8 (pt) compostos de tiazol que modulam a atividade da proteína hsp90, métodos de inibição, tratamento e indução associados e composição farmacêutica
BRPI0413580A (pt) composto, composição farmacêutica, e, métodos para tratar ou prevenir cáncer em um mamìfero em necessidade de tal tratamento, para modular a formação do fuso mitótico e para inibir a cinesina mitótica ksp
Lu et al. Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway
RU2010137032A (ru) Конъюгаты паклитаксела с полимером и способы лечения рака
BRPI0414736A (pt) 5-aril-pirimidinas como agentes anticáncer
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
BR0112038A (pt) Triazolopirimidinas substituìdas como agentes anticâncer
BRPI0411098A (pt) benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos
BRPI0511139A (pt) compostos, composição farmacêutica que compreende os mesmos, método para inibir atividade de quinase aurora em uma célula e método para tratamento de um distúrbio mediado por quinase aurora em um paciente
PL2484365T3 (pl) Kompozycje i sposoby leczenia chorób neowaskularnych
CU20100062A7 (es) Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BRPI0905687A8 (pt) composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto
BR112012008325A2 (pt) N-4 ( - ( ( 3- ( 2 - amino-4 pirimidinil) -2 -piridinil) oxi) fenil) -4- (4-metil-2-tienil) -1- ftalazinamina para uso no tratamento de câncer resistente a agente antimitótico
BRPI0409926A (pt) saposina c-dops: um agente antitumor
BR9908125A (pt) Composto, composto dimérico, composição farmacêutica, uso do composto, processo compreendendo inibir células de câncer, e, processo terapêutico
BRPI0410875A (pt) método de inibição do crescimento de tumor com anticorpos de fator antitecido
BRPI0715609A2 (pt) Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica
ATE419249T1 (de) Inhibitoren von mitotischem kinesin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.